Key result
Impella weaning requires hemodynamic stability without inotropes and prior management of coronary and valvular disease.
Why the study?
Weaning patients from Impella is complex and requires careful evaluation of underlying disease, monitoring, and medical management to optimize heart recovery and mobilization.
Provides clinical guidance on the complex process of weaning patients from Impella support, emphasizing the need for hemodynamic stability, end-organ recovery, and appropriate monitoring.
Answers are grounded in this paper and cite their sources.
May inform Impella weaning strategies; leaves open prospective validation of specific criteria.
Weaning of patients from Impella is complex and includes evaluation of the underlying disease, which is essential for estimating the potential for heart recovery. Monitoring during the weaning phase with echocardiography and pulmonary artery catheters will be discussed, as well as the use of intravenous and oral heart failure drugs. Patients who are candidates for weaning must be stable, without inotropes, and must have recovered from acute end-organ damage. Coronary artery disease and valvular heart diseases should be appropriately addressed before weaning to take the maximum advantage of haemodynamic stability provided by the support and to maximize the possibility of weaning. Tips and tricks for the mobilization of Impella patients will also be discussed.
No takes yet. Share an insight, caveat, or question.
Bertoldi et al. (2021) conducted a review in Patients requiring Impella support. Weaning from Impella and mobilization was evaluated. Weaning from Impella requires careful evaluation of underlying disease, hemodynamic stability without inotropes, and appropriate management of coronary and valvular diseases prior to weaning.
Synapse has enriched 10 related papers. Consider them for comparative context: